About Sapien Biosciences Private Limited
Data last updated:
Sapien Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Apollo Hospitals Enterprise Limited and recognised as a startup by DPIIT. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 12 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2012PTC080254. Its GSTIN is 36AARCS5114M1ZU (Telangana).
The company has an authorised share capital of ₹2.7 Cr and a paid-up capital of ₹1.43 Lakh. It is led by directors including Sridhar Rohini and Nirmal Kumar Ganguly.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 2 – 293/82/J – III/Dh/900 1st Floor Aherf Building Apollo Hospitals Jubilee Hills, Hyderabad, Telangana, India – 500096.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.62 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹32.39 Lakh (net margin -9%) and EBITDA of -₹23.72 Lakh (EBITDA margin -6.6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 3% over five years.
The company has about 34 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sapien Biosciences. The company has 6 deals on record (3 funding rounds, 2 acquisitions, 1 secondary share transfer), with disclosed funding of ₹1.6 Cr; the latest was in March 2017. Its 10 peer companies in the Healthcare industry (Biosciences, Preventive Healthcare Services) are compared by revenue, 5 larger and 5 smaller; the largest is Biomax Health Care (India) Private Limited with revenue of ₹3.64 Cr. The company has 9 MSME Form 1 returns on record between 2017 and 2021, listing 28 overdue payments to 5 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sapienbio.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address8 – 2 – 293/82/J – III/Dh/900 1st Floor Aherf Building Apollo Hospitals Jubilee Hills, Hyderabad, Telangana, India – 500096
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sapien Biosciences Private Limited
The main business activity of Sapien Biosciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sapien Biosciences Private Limited FY 2025 filings available
Sapien Biosciences Private Limited reported revenue of ₹3.62 Cr (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sapien Biosciences Private Limited
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sapien Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹23.72 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹32.39 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sapien Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sapien Biosciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sapien Biosciences Private Limited
Sapien Biosciences Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Biosciences, Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biomax Health Care (India) Private Limited | ₹3.64 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Tanvi Medicare Private Limited | ₹3.64 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
| Mohit Herbs Private Limited | ₹3.64 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Nadiad, Gujarat, India |
| Ozone Diagnostic Private Limited | ₹3.62 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Akola, Maharashtra, India |
| DMB Orthosport Private Limited | ₹3.62 Cr (FY 2024) | •••• | •••• | 43.0% | •••• | Gurgaon, Haryana, India |
| Sapien Biosciences Private Limited this company | ₹3.62 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Hyderabad, Telangana, India |
| Akv Wellness LLP | ₹3.61 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| Harleys Clinic Private Limited | ₹3.61 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Mumbai, Maharashtra, India |
| Suncity Fitness and Wellness Private Limited | ₹3.6 Cr (FY 2018) | •••• | •••• | -28.0% | •••• | Surat, Gujarat, India |
| Physmedrehab Private Limited | ₹3.6 Cr (FY 2024) | •••• | •••• | 94.0% | •••• | Bangalore, Karnataka, India |
| Aditya Nursing Home Private Limited | ₹3.6 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Sapien Biosciences by revenue in the Healthcare industry (Biosciences, Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sapien Biosciences Private Limited
Sapien Biosciences Private Limited is audited by KARRA & CO. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KARRA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sapien Biosciences Private Limited
Sapien Biosciences has 5 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridhar Rohini | Director | 18 May 2024 | 2 Years 4 Months | Current |
| Nirmal Kumar Ganguly | Director | 29 Apr 2017 | 9 Years 5 Months | Current |
| Sreevatsa Natarajan Gopinath Also directs: Anpv Farms & Resorts LLP, Dyuloka Resorts LLP, Saarum Sciences Private Limited and 1 more | Director | 17 Nov 2012 | 13 Years 10 Months | Current |
| Jugnu Jain | Director | 17 Nov 2012 | 13 Years 10 Months | Current |
| Ishita Shively | Director | 09 May 2018 | 8 Years 5 Months | Current |
Ownership and Shareholding of Sapien Biosciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sapien Biosciences Private Limited
Sapien Biosciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Sapien Biosciences Private Limited
Sapien Biosciences Private Limited has 6 deals on record (3 funding rounds, 2 acquisitions, 1 secondary share transfer), with disclosed funding of ₹1.6 Cr; the latest was in March 2017.
Deals on record (2 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2012 | Acquisition | ₹1 Cr | Buyer: Apollo Hospitals Enterprise Limited |
| Nov 2012 | Acquisition | ₹1 Lakh | Buyer: Apollo Hospitals Enterprise Limited Seller: 2 individuals |
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Sapien Biosciences Private Limited
Sapien Biosciences Private Limited has 9 MSME Form 1 returns on record between 2017 and 2021, listing 28 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Sequel Logistics Private Limited | •••• | •••• | •••• |
| Lakshmi Venkateshwara Enterprises | •••• | •••• | •••• |
| Bharat Science Apparatus Workshops | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 9 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Sapien Biosciences Private Limited
Sapien Biosciences operates one associated brand: Sapien Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biobanking services are offered for biomarker discovery and drug development. | sapienbio.co.in |
Employees and EPFO Compliance at Sapien Biosciences Private Limited
Sapien Biosciences Private Limited has a workforce of 34 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Sapien Biosciences Private Limited
Sapien Biosciences has one previous CIN (Corporate Identification Number): U73100AP2012PTC080254. The current CIN is U73100TG2012PTC080254, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2012PTC080254 | Current |
| U73100AP2012PTC080254 | Previous |
Recent Activity on Sapien Biosciences Private Limited
Sapien Biosciences Private Limited has 13 board changes on record since 2012: 5 appointments and 8 cessations. The latest: Sridhar Rohini ceased to be Additional Director on 29 Sep 2024.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sapien Biosciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sapien Biosciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sapien Biosciences Private Limited
Sapien Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AARCS5114M1ZU | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sapien Biosciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sapien Biosciences Private Limited
Sapien Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 12 April 2012 (14+ years old) and is registered under CIN U73100TG2012PTC080254.
Sapien Biosciences reported revenue of ₹3.62 Cr for FY 2025 (down 35% YoY).
Sapien Biosciences has 5 current directors:
- Sridhar Rohini - Director
- Nirmal Kumar Ganguly - Director
- Sreevatsa Natarajan Gopinath - Director
- Jugnu Jain - Director
- Ishita Shively - Director
Sapien Biosciences reported a net loss of ₹32.39 Lakh (net margin -9%) and EBITDA of -₹23.72 Lakh (EBITDA margin -6.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sapien Biosciences is 13% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 35%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sapien Biosciences is 36AARCS5114M1ZU, registered in Telangana.
The CIN (Corporate Identification Number) of Sapien Biosciences is U73100TG2012PTC080254. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sapien Biosciences was incorporated on 12 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sapien Biosciences has 6 deals on record (3 funding rounds, 2 acquisitions, 1 secondary share transfer), with disclosed funding of ₹1.6 Cr; the latest was in March 2017.
The peers of Sapien Biosciences by revenue are Biomax Health Care (India) Private Limited, Tanvi Medicare Private Limited, Mohit Herbs Private Limited, Ozone Diagnostic Private Limited, DMB Orthosport Private Limited and 5 more, all in the Healthcare industry (Biosciences, Preventive Healthcare Services).
Sridhar Rohini ceased to be Additional Director on 29 Sep 2024. Sridhar Rohini was appointed as Director on 18 May 2024. Ishita Shively was appointed as Director on 09 May 2018. Sapien Biosciences has 13 board changes on record in total.
Yes, Sapien Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).